MarketPulse
Home
About Market Pulse
Featured Companies
Our Services
Resources
Stock Charts
Contact
LOG IN
Get Market Pulse's
stock picks
in your inbox! Sign up for our free Newsletter today!
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Amarin Corp Plc
(NQ:
AMRN
)
6.470
USD
-0.130 (-1.97%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
6.640
Bid (Size)
6.460 (20800)
Ask (Size)
6.470 (30700)
Prev. Close
6.600
Today's Range
6.450 - 6.700
52wk Range
6.250 - 15.96
Shares Outstanding
150,312,023
Dividend Yield
N/A
Top News
More News
Bio-Wire Equity Surveillance – Closing Bell 6/19/2013
June 19, 2013
Wednesday, June 19th, 2013 DJIA: -1.35% ?15,112.19 S&P 500: -1.39% ? 1628.93 NASDAQ: -1.12% ?3443.20 NASDAQ Biotech: -2.08% ?1,805.07 NYSE Arca – Pharma Index: -1.55% ?424.87 Big pharma (Mkt Cap $10...
Read More
category
NKTR
,
REGN
,
QCOR
, and 3 more.
from
Bio-Wire.Com
Amarin (AMRN) Vascepa sNDA Set for Oct. 16, 2013, According to FDA
June 19, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8430135 for the full story.
Read More
from
StreetInsider.com News Articles
More News
Read More
Amarin Informed by FDA of October 16th Advisory Committee Date in Connection With Supplemental New Drug Application (sNDA) for Vascepa(R) in the Treatment of Patients With High Triglycerides (>200 mg/
June 19, 2013
from
GlobeNewswire News Releases
Amarin (AMRN) Vascepa Prescriptions Still Showing Strong Growth (GSK)
June 19, 2013
from
StreetInsider.com News Articles
7 Biotechnology Stocks to Sell Now
June 19, 2013
category
NASDAQ:TSRX
,
NASDAQ:ACHN
,
NASDAQ:EXEL
, and 5 more.
from
InvestorPlace - Latest Headlines
Amarin (AMRN) NCE Delay Not all Negative - MKM Partners
June 18, 2013
from
StreetInsider.com News Articles
Bio-Wire Option Surveillance – 6/14/2013
June 14, 2013
category
SNTS
,
AMRN
,
MYGN
, and 2 more.
from
Bio-Wire.Com
Amarin (AMRN) Vascepa NCE Not in Latest FDA Orange Book Update
June 14, 2013
from
StreetInsider.com News Articles
7 Biotechnology Stocks to Sell Now
June 12, 2013
category
NASDAQ:TSRX
,
NASDAQ:ACHN
,
NASDAQ:EXEL
, and 5 more.
from
InvestorPlace - Latest Headlines
Bio-Wire Equity Surveillance – Closing Bell 6/7/2013
June 07, 2013
category
ICUI
,
QCOR
,
AMRN
, and 4 more.
from
Bio-Wire.Com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stock Information and Stock Picks Each Month